Background
hypercholesterolemia
HYPERCHOLESTEROLEMIA
Ezetimibe (Ezetrol), as a non-statin lipid-lowering approach, was approved by US Food and Drug Administration (FDA) in patients with hypercholesterolemia (In this study, it is meaningful to investigate the pharmacokinetic characteristics and bioequivalence of single-dose ezetimibe tablets and Ezetrol® in Chinese healthy subjects under fasting and fed conditions.